Administration of Recombinant Tissue Plasminogen Activator for Sulcal Artery Syndrome

The use of rtPA can result in clinical improvement in symptoms from spinal cord infarction. Spinal cord infarction is a rare type of ischemic stroke and often an elusive diagnosis. The study of recombinant tissue plasminogen activator (rtPA) in spinal cord infarction has been limited due to the rarity of this condition. Here, we present the case of an adult man with spinal cord infarction in a sulcal artery distribution who clinically improved following rtPA administration.

Read article at journal's website

Related Articles

Responses

Your email address will not be published. Required fields are marked *